Back to MW MARSHALL WACE, LLP

PRLDPRLD
14 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PRELUDE THERAPEUTICS INC

Yes. Marshall Wace holds 190,692 shares of PRLD (Prelude Therapeutics), worth $1M, as of its Q2 2026 13F filing. It reduced the position by 168,214 shares (-46.9%) from Q1 2026. Marshall Wace has held PRLD since Q4 2025, across 3 quarterly 13F filings.

Current Value

$1M

Current Shares

190,692

Total Value Change

-$253,613

Total Shares Change

+161,377

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
190,692
-46.9%
$1M0.0%$5.33
0
2026-Q1
Increased
358,906
+31.0%
$1.2M0.0%$2.63
32
2025-Q4
New
273,883
-
$794,2600.0%$2.84
34
2025-Q3
Exited
0
-100.0%
$00.0%$1.37
0
2025-Q2
New
41,747
-
$33,8150.0%$0.79
30
2025-Q1
Exited
0
-100.0%
$00.0%$0.80
0
2024-Q4
Increased
392,155
+9.2%
$498,0380.0%$1.21
26
2024-Q3
New
359,137
-
$743,4140.0%$2.12
34
2022-Q3
Exited
0
-100.0%
$00.0%$6.52
0
2022-Q2
Decreased
45,716
-59.1%
$238,0000.0%$5.18
0
2022-Q1
Decreased
111,777
-58.3%
$772,0000.0%$6.96
0
2021-Q4
New
268,018
-
$3.3M0.0%$12.76
37
2021-Q2
Exited
0
-100.0%
$00.0%$30.02
0
2021-Q1
New
29,315
-
$1.3M0.0%$39.27
35

Other major holders of PRLD: BAKER BROS. ADVISORS LP, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used